A recent study suggests that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who end traditional lifestyle regimens.
Published data in a prominent medical journal shows that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying such medications should be aware of the danger of rapid weight regain when the medication concludes," stated expert Dr. Susan Jebb.
Such speed of recovery means a reversion to starting weight in about one and a half years.
Analyzing Approaches
The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Researchers emphasize that people who lose weight through dieting typically see a slower creep back—approximately 0.1 kg a month—after stopping.
Understanding the Quick Regain
Experts propose the mechanism of the drugs explains the amplified regain.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making binge eating far more likely."
An Ongoing Disease?
Health authorities recommend the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Professionals contend that, considering the likelihood of weight regain, the treatment might need to be long-term.
This perspective is echoed by pharmaceutical companies, who say that the findings "highlight the long-term nature of excess weight," comparing it to managing diseases like hypertension.
User Accounts
People who have stopped the medication describe a sudden return of cravings.
"It was like a switch that goes on and I was suddenly extremely hungry," said a patient.
This challenge is exacerbated if patients have not developed lasting dietary or behavioural modifications during treatment.
Widespread Use
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle management.